BILLERICA, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ: QTRX) today announced an exclusive distribution agreement with Sherman Abrams Laboratory, a Brooklyn-based clinical and anatomic pathology lab, to bring its LucentAD® Complete blood tests to patients across New Jersey and the surrounding area. LucentAD Complete from Quanterix is powered by the SIMOA® platform and is one of the first blood-based tests to screen for multiple biomarkers associated with Alzheimer’s disease, helping p

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.